DOCSLIB.ORG

A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro Or Nano Vesicles for Nebulization

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro Or Nano Vesicles for Nebulization CORE Metadata, citation and similar papers at core.ac.uk Provided by CLoK Article A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization Khan, Iftikhar, Lau, Katie, Bnyan, Ruba, Houacine, Chahinez, Roberts, Matthew, Isreb, Abdullah, Elhissi, Abdelbary and Yousaf, Sakib Available at http://clok.uclan.ac.uk/33622/ Khan, Iftikhar, Lau, Katie, Bnyan, Ruba, Houacine, Chahinez, Roberts, Matthew, Isreb, Abdullah ORCID: 0000-0001-9939-6161, Elhissi, Abdelbary and Yousaf, Sakib (2020) A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization. Pharmaceutical Research, 37 (116). ISSN 0724-8741 It is advisable to refer to the publisher’s version if you intend to cite from the work. http://dx.doi.org/10.1007/s11095-020-02840-w For more information about UCLan’s research in this area go to http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>. For information about Research generally at UCLan please go to http://www.uclan.ac.uk/research/ All outputs in CLoK are protected by Intellectual Property Rights law, including Copyright law. Copyright, IPR and Moral Rights for the works on this site are retained by the individual authors and/or other copyright owners. Terms and conditions for use of this material are defined in the http://clok.uclan.ac.uk/policies/ CLoK Central Lancashire online Knowledge www.clok.uclan.ac.uk Pharm Res (2020) 37:116 https://doi.org/10.1007/s11095-020-02840-w RESEARCH PAPER A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization Iftikhar Khan1 & Katie Lau 1 & Ruba Bnyan 1 & Chahinez Houacine 2 & Matthew Roberts2 & Abdullah Isreb2 & Abdelbary Elhissi3 & Sakib Yousaf2 Received: 30 August 2019 /Accepted: 13 May 2020 # The Author(s) 2020 ABSTRACT by spray drying (SD) to get a dry powder of these formulations Purpose The aim of this study was to develop novel as F3SDN, F6SDN and F9SDN, and gave high yield (>53%) paclitaxel-loaded proliposome tablet formulations for pulmo- and exhibited poor to very poor compressibility index values via nary drug delivery. Carr’s Index. Post tablet manufacturing, F3 tablets formula- Method Proliposome powder formulations (i.e. F1 – F27) tion showed uniform weight uniformity (129.40 ± 3.85 mg), were prepared employing Lactose monohydrate (LMH), good crushing strength (14.08 ± 1.95 N), precise tablet thick- Microcrystalline cellulose (MCC) or Starch as a carbohydrate ness (2.33 ± 0.51 mm) and a short disintegration time of carriers and Soya phosphatidylcholine (SPC), Hydrogenated 14.35 ± 0.56 min, passing all quality control tests in accor- soya phosphatidylcholine (HSPC) or Dimyristoly phosphati- dance with British Pharmacopeia (BP). Upon nebulization of dylcholine (DMPC) as a phospholipid. Proliposome powder F3 tablets formulation, Ultrasonic nebulizer showed better formulations were prepared in 1:5, 1:15 or 1:25 w/w lipid nebulization time (8.75 ± 0.86 min) and high output rate phase to carrier ratio (lipid phase; comprising of phospholipid (421.06 ± 7.19 mg/min) when compared to Vibrating mesh and cholesterol in 1:1 M ratio) and Paclitaxel (PTX) was used nebulizer. PTX-loaded F3 tablet formulations were identified as model anticancer drug. as toxic (60% cell viability) to cancer MRC-5 SV2 cell lines Results Based on flowability studies, out of 27 formulations; while safe to normal MRC-5 cell lines. F3, F6, and F9 formulations were selected as they exhibited an Conclusion Overall, in this study LMH was identified as a excellent angle of repose (AOR) (17.24 ± 0.43, 16.41 ± 0.52 superior carbohydrate carrier for proliposome tablet manu- and 15.16 ± 0.72°), comparatively lower size of vesicles (i.e. facturing in a 1:25 w/w lipid to carrier ratio for in-vitro nebu- 5.35 ± 0.76, 6.27 ± 0.59 and 5.43 ± 0.68 μm) and good com- lization via Ultrasonic nebulizer. pressibility index (14.81 ± 0.36, 15.01 ± 0.35 and 14.56 ± 0.14) via Carr’s index. The selected formulations were re- KEY WORDS nebulizer . paclitaxel . proliposome . quality duced into Nano (N) vesicles via probe sonication, followed control testing . tablets Electronic supplementary material The online version of this article (https://doi.org/10.1007/s11095-020-02840-w) contains supplementary material, which is available to authorized users. * Iftikhar Khan ABBREVIATION [email protected]; [email protected] AOR Angle of repose * Sakib Yousaf DPMC Dimyristoly phosphatidylcholine [email protected] F Formulation FD Freeze dried 1 School of Pharmacy and Biomolecular Sciences, Liverpool John Moores FDM Freeze dried Micro University, Liverpool L3 3AF,UK FDN Freeze dried Nano 2 School of Pharmacy and Biomedical Sciences, University of Central HSPC Hydrogenated soya phosphatidylcholine Lancashire, Preston PR1 2HE, UK LMH Lactose monohydrate 3 Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, MCC Microcrystalline cellulose P.O. Box 2713, Doha, Qatar M Micro 116 Page 2 of 19 Pharm Res (2020) 37:116 N Nano pulmonary administration of PTX has been reported to en- PS Probe sonication hance drug accumulation within the lung and reduce systemic PTX Paclitaxel distribution, which in turn exhibited reduced systemic toxicity SEM Scanning electron microscope (10). Similarly, an in-vitro study demonstrated complete tu- SD Spray dried mour remission and reduced systemic toxicity post nebuliza- SDM Spray dried Micro tion of PTX delivered using solid lipid nanoparticles (11). SDN Spray dried Nano Likewise, transfersome/protransfersome is an another lipid- SPC Soya phosphatidylcholine based drug delivery system designed to suit different situations TEM Transmission electron microscope and delivery scenarios, however unlike liposome and solid TSI Two Stage Impinge lipid nanoparticles incorporate a surfactant as the primary PDI Polydispersity index component, imbibing transfersome with elasticity in terms of their structure enhancing delivery performance, also demon- strated cytotoxic activity against cancer cells (12). A compari- INTRODUCTION son between PTX liposome formulation as aerosol and the intravenous administration of two commercial formulations The usage of Paclitaxel (PTX) as an anticancer agent in the was conducted by Joshi, Shirsath (13). The study demonstrat- treatment of a plethora of cancers (e.g. lung, breast and neck) ed no pulmonary toxicity following aerosol treatment with is well documented (1). PTX appears as needle or fine white to 75% more enhanced metastases inhibition, in comparison to off-white crystalline powder with a molecular weight of parenteral administration (13). 853.91 g/mol (chemical structure of PTX in supplementary The biocompatibility and biodegradability of liposomes data (Fig. a)). PTX storage temperature is 0°C for short term (lipid vesicles) are well-established properties (14). Being struc- and − 20°C for long term in desiccator. A number of physi- turally similar to biological membranes, unlike poly- cochemical properties, like; size, size distribution, entrapment oxyethylated castor oil, are not associated with hypersensitiv- efficiency and zeta potential are critical parameters for PTX- ity reactions (15,16). Hydrophobic compounds are commonly loaded formulations. PTX is associated with a number of entrapped within the concentric bilayers of the vesicles, physicochemical limitations, two significant issues include; whereas hydrophilic molecules position into the central aque- lower aqueous solubility and cellular permeability (2,3). A ous core (17). A number of studies have demonstrated that number of approaches have been employed to overcome PTX can be entrapped into liposomes bilayers without these drawbacks, including the use of cyclodextrins, which PEGylation (18–22). Additionally, PTX entrapment and sta- significantly improve PTX water solubility without altering bility in bilayers may be affected by a number of factors (e.g. its cytostatic activity (4). A commercially available parenteral presence of saturated and unsaturated hydrocarbon chains of formulation under the name of Taxol® is available on the lipids, PEGylation, fusion or aggregation, and the presence or market, which has addressed the compounds poor solubility absence of triglycerides (23)). PEGylation coating of liposomes by formulation with poly-oxyethylated castor oil and ethanol may also prolong retention time, reduce recognition and up- in a 50:50 v/v ratio followed by 5–20 times dilution. However, take by phagocytic cells, offer protection from opsonin binding there are established side-effects associated with poly- in plasma (24–26), thus improving pharmacokinetic and oxyethylated castor oil, namely, laboured breathing and hy- pharmacodynamics properties (27) (i.e. long circulating lipo- persensitivity reactions (5). Thus, there is a clear need for a somes) (28). As formulations, drug-loaded liposomes delivered biocompatible formulation, which enhances cellular perme- to the lungs via nebulization have been associated with a lower ability and water solubility. Previous research has addressed incidence of system side-effects and improved therapeutic ef- this need through formulation of PTX loaded onto albumin fect (29). Arikace® is a liposome formulation containing ami- nanoparticles, under the product Abraxane® (currently under kacin for the treatment of cystic fibrosis via nebulization is clinical trial). Whilst this has been observed to improve
Load more

Recommended publications
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
    [Show full text]
  • Chapter 1 Controlling Drug Delivery
    chapter 1 Controlling drug delivery Overview In this chapter we will: & differentiate drug delivery systems according to their physical state & differentiate drug delivery systems according to their route of administration & differentiate drug delivery systems according to their type of drug release & discuss drug transport across epithelial barriers. Introduction KeyPoints & Continued developments in Pharmacotherapy can be defined as the treatment chemistry, molecular biology and prevention of illness and disease by means of and genomics support the drugs of chemical or biological origin. It ranks discovery and developments among the most important methods of medical of new drugs and new drug treatment, together with surgery, physical targets. & treatment, radiation and psychotherapy. There The drug delivery system are many success stories concerning the use of employed can control the pharmacological action of a drugs and vaccines in the treatment, prevention drug, influencing its and in some cases even eradication of diseases pharmacokinetic and (e.g. smallpox, which is currently the only subsequent therapeutic human infectious disease completely profile. eradicated). Although it is almost impossible to estimate the exact extent of the impact of pharmacotherapy on human health, there can be no doubt that pharmacotherapy, together with improved sanitation, better diet and better housing, has improved people’s health, life expectancy and quality of life. Tip Unprecedented developments in genomics Combinatorial chemistry is a way to and molecular biology today offer a plethora of build a variety of structurally related new drug targets. The use of modern chemical drug compounds rapidly and synthetic methods (such as combinatorial systematically. These are assembled chemistry) enables the syntheses of a large from a range of molecular entities number of new drug candidates in shorter times which are put together in different ‘ ’ than ever before.
    [Show full text]
  • Dissolution Testing of Orally Disintegrating Tablets
    dx.doi.org/10.14227/DT100203P6 Dissolution Testing of Orally Disintegrating Tablets James Klancke Sr. Director, Analytical Development, CIMA LABS INC, Brooklyn Park, MN email correspondence: [email protected] Abstract Orally disintegrating tablets (ODT) are solid dosage forms that disintegrate in the oral cavity leaving an easy-to-swallow residue.The disintegration times are generally less than one minute.For orally disinte- grating tablets,taste-masking of bitter or objectional-tasting drug substances is critical.The taste-masking aspect plays a significant role in dissolution method development,specifications,and testing.The USP 2 paddle apparatus is the most suitable and common choice for orally disintegrating tablets.Discriminating, robust dissolution methods are extremely useful for monitoring process optimization and changes during scale-up of taste-masked bulk drug and tablet manufacture. Introduction rally disintegrating tablets contain a wide The development of dissolution methods for variety of pharmaceutical actives covering orally disintegrating tablets is comparable to the Omany therapeutic categories,and can be approach taken for conventional tablets,and is particularly good applications for pediatric and practically identical when the orally disintegrating geriatric treatments.The time for disintegration of tablet does not utilize taste masking.The reference orally disintegrating tablets is generally considered listed drug may have dissolution conditions in a to be less than one minute [1-4],although patients USP
    [Show full text]
  • Titration of Aspirin Tablets
    Bellevue College | CHEM& 161 Titration of Aspirin Tablets In this lab, you will determine the percent purity of two commercially available aspiring tablets using an acid-base titration. In general, an acid and a base react to produce a salt and water by transferring a proton (H+): HA (aq) + NaOH (aq) H2O (l) + NaA (aq) (1) acid base salt The active ingredient in aspirin, and the chemical for which aspirin is the common name, is acetylsalicylic acid. To determine the amount of aspirin (acetylsalicylic acid) in a sample, the precise volume and concentration of the NaOH, and the overall reaction, must be known. The NaOH serves as a secondary standard, because its concentration can change over time. To find the precise concentration of the NaOH, it must be titrated against a primary standard, an acid that dissolves completely in water, has a high molar mass, that remains pure upon standing, and is not hygroscopic (tending to attract water from the air). Because sodium hydroxide is hygroscopic, it draws water from its surroundings. This mean one cannot simply weigh out a sample of sodium hydroxide, dissolve it in water, and determine the number of moles of sodium hydroxide present using the mass recorded, since any sample of sodium hydroxide is likely to be a mixture of sodium hydroxide and water. Thus, the most common way to determine the concentration of any sodium hydroxide solution is by titration. Determining the precise concentration of NaOH using a primary standard is called standardization. You will first standardize your NaOH solution, and then use it to analyze aspirin tablets for their aspirin content and purity.
    [Show full text]
  • Formulation and Evaluation of Bioadhesive Tablets of Metronidazole from Gellan Gum and Gelatin
    Sylvester Okhuelegbe Eraga et al. / Journal of Pharmacy Research 2014,8(8),1132-1139 Research Article Available online through ISSN: 0974-6943 http://jprsolutions.info Formulation and evaluation of bioadhesive tablets of Metronidazole from Gellan gum and gelatin Sylvester Okhuelegbe Eraga* and Magnus Amara Iwuagwu Department of Pharmaceutics and Pharmaceutical Technology,Faculty of Pharmacy, University of Benin, PMB 1154, Benin City, 300001, Nigeria. Received on:30-06-2014; Revised on: 19-07-2014; Accepted on:09-08-2014 ABSTRACT Background: The delivery of drugs using a combination of bio-polymers is gaining extensive grounds in the development of newer drug delivery systems. In this work the formulation, evaluation and release profiles of metronidazole bioadhesive tablets formulated with admix- tures of gellan gum and gelatin were investigated. Methods: Aqueous dispersions of gellan gum and gelatin in ratios of 1:1, 1:2, 2:1, 1:4, 1:0 and 0:1 were prepared in distilled water. Metronidazole tablets were prepared with the dispersions by wet granulation. The bioadhesive strengths of the dispersions and tablets were determined using the coated bead and tensiometric methods, respectively. Tablet parameters evaluated were weight uniformity, friability, hardness, disintegration time, content of active, swelling index and tablet erosion. Release studies were carried out in simulated intestinal and gastric fluid. Results: All batches of tablets met compendial specifications with regard to weight uniformity, friability, hardness and content of active except disintegration times. Tablets prepared with gelatin alone had the highest swelling index and bioadhesive strength (40 %, 5 h and 0.253 Nm-1) while those prepared with gellan gum alone had the highest percentage tablet erosion and least bioadhesive strength (15 % and 0.085 Nm-1).
    [Show full text]
  • [email protected] CAPSULE.COM Capsule Is Rebuilding the Pharmacy Industry from the Inside Out
    [email protected] CAPSULE.COM Capsule is rebuilding the pharmacy industry from the inside out with an emotionally resonant experience and technology that enables customized outcomes for doctors, hospitals, insurers, and manufacturers. 2 1 in 2 Prescriptions that are never picked up from pharmacies. Whether you’re 40% Percentage of people who have sick or just sick to return to their pharmacy due of your pharmacy to out-of-stock prescriptions. In the healthcare industry, businesses often forget that behind all the craziness of the system, we’re all just people looking after other people. At Capsule, we have solved the familiar frustrations 60 mins of conventional pharmacies — eliminating wait Typical time spent waiting for times, building predictive inventory tools to ensure a prescription to be filled. medications are in stock when you need them, putting price transparency at the core of the customer and doctor experience, creating a modern way to interact with your pharmacist, and offering smart refills so you never miss a dose of your medication. This frictionless experience is at the heart of 26% the first emotionally resonant brand in healthcare. Percentage of people who would recommend their chain pharmacy to a friend. 90% Percentage of prescriptions filled at retail pharmacies, up from 82% in 2009. 3 Ryan Miller 1520 6TH AVENUE APT. 31F, NEW YORK NY 10020 Atorvastatin 10mg Subsituted for Lipitor, Mfg: San TAKE 1 TABLET BY MOUTH DAILY Quantity: 30 Rells: None Prescribed by: Dr. John Walters Rx#: 01000064-00 Expires: 2/9/2016 FILLED BY SONIA PATEL ON 2/9/2016 New York NY 10001 113 W 25th Street Capsule Corporation CAPSULE PHARMACY (212) 675-3900 [email protected] than the patient for whom prescribed transfer of this drug to any person other CAUTION: Federal law prohibits Don’t be shy.
    [Show full text]
  • Extended Release Drug Delivery Technology
    DRUG DELIVERY & FORMULATION Extended release drug delivery technology By providing smooth plasma levels of drug over longer periods of time, extended release drug delivery technology can minimise side effects, improve effi cacy and – by enabling once-daily dosing – maximise patient compliance. Peter Fyhr and Ken Downie, Amarin Development AB xtended release oral drug formulations have methylcellulose (HPMC) and hydroxypropyl cellu- Ebeen used since the 1960s to enhance perform- lose (HPC), and then formed as a tablet by conven- ance and increase patient compliance. By incorpo- tional compression. Release from these tablets takes rating the dose for 24 hours into one tablet from place by a combination of physical phenomena. which the drug is slowly released, peaks of high Water diffuses into the tablet, swells the polymer plasma concentration and troughs of low plasma and dissolves the drug, whereupon the drug may concentration can be prevented. This helps avoid diffuse out to be absorbed. If the drug diffuses out the side effects associated with high concentrations faster than the polymer dissolves, the release rate and the lack of activity associated with low concen- declines with time. Water penetration also depends trations – giving better overall therapy. In addition, on factors such as tablet porosity, and this makes in the treatment of diseases that are asymptomatic matrix tablets inherently variable and diffi cult to – such as hypertension – patients generally remem- formulate. If the medication is taken with food, ber morning and evening medication, but tend the increased mechanical stress leads to an increased to forget doses in between. Once- or twice-daily release rate and a higher risk of dose-dumping.
    [Show full text]
  • Asian Journal of Pharmaceutical Education and Research Oral Thin
    Available online on www.ajper.com Asian Journal of Pharmaceutical Education and Research Vol -4, Issue-2, April-June 2015 ISSN: 2278-7496 REVIEW ARTICLE Oral thin films: an overview KanikaDhote1, Vinod Dhote2, Subhendu Mishra1 1 Ravishankar College of Pharmacy, Bhopal(M.P) 2 Truba Institute of pharmacy, Bhopal (M.P) Article Received on Abstract: 10 March 2015 Oral thin films (OTFs) are the most advanced and promising new approaches for drug delivery as it offers more flexibility and comfort. These enable an ease of administration, as there is no need to drink high amounts of liquids or swallow large solid dosage forms Also it Accepted on improves the efficacy of APIs by dissolving within minute in oral cavity after the contact with less saliva as 22 March 2014 compared to fast dissolving tablets, without chewing and no need of water for administration. OTF offers an alternative to tablets, syrups or suppositories for the treatment of vomiting and nausea, especially for the pediatric population. *Correspondence for The oral thin-film technology is still in the Author: beginning stages and but most popular because it fulfils all the need of patients. In due course, these formulations having APIs will be commercially launched using the oral Kanika Dhote* film technology. These can be prepared using hydrophilic Ravishankar College of polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via Pharmacy, Bhopal. dissolution when contact with liquid is made. Water-soluble polymers are used as film formers for fast dissolving films. It State: Madhya Pradesh, seems that the value on the whole oral thin film market will Pin No.
    [Show full text]
  • Oral Films - Patient Compliant Dosage Form for Pediatrics S Malke, S Shidhaye, J Desai, V Kadam
    The Internet Journal of Pediatrics and Neonatology ISPUB.COM Volume 11 Number 2 Oral Films - Patient Compliant Dosage Form For Pediatrics S Malke, S Shidhaye, J Desai, V Kadam Citation S Malke, S Shidhaye, J Desai, V Kadam. Oral Films - Patient Compliant Dosage Form For Pediatrics. The Internet Journal of Pediatrics and Neonatology. 2009 Volume 11 Number 2. Abstract Pediatric and geriatric patients, have difficulty swallowing or chewing solid dosage forms. Many pediatric and geriatric patients are unwilling to take solid preparations due to fear of choking. Even with fast dissolving tablets there is a fear of choking due to its tablet type appearance. Hence oral film drug delivery is a better alternative in such cases. The oral films are formulated using polymers, plasticizers, flavors, colors and sweeteners. The oral films are manufactured using solvent casting method, rolling method, extrusion method and solid dispersion method. The films are evaluated for dimensions, disintegration, dissolution, tensile strength and folding endurance. It has many applications like in taste masking, immediate release and sustained release formulation INTRODUCTION Intraoral fast-dissolving drug delivery system is placed on Many pharmaceutical dosages are administered in the form the top or the floor of the tongue. It is retained at the site of of pills, granules, powders, and liquids. Generally, a pill application and rapidly releases the active agent for local design is for swallowing intact or chewing to deliver a and/or systemic absorption. This drug delivery system can precise dosage of medication to patients. The pills, which be provided in various packaging configurations, ranging include tablets and capsules, are able to retain their shapes from unit-dose pouches to multiple-dose blister packages.
    [Show full text]
  • Oral Thin Film Drug Delivery Technology Leapfrogs Orally
    Oral Thin Film Drug Delivery Technology Leapfrogs Orally Disintegrating Tablet Technology Technology Catalysts International, consultants to the pharmaceutical industry, announced that its research on trends and developments in drug delivery has identified a breakthrough technology that accelerates pharmaceutical product market introductions by generic and drug delivery companies. Falls Church, VA (PR Web) January 25, 2006 -- Technology Catalysts International, consultants to the pharmaceutical industry, announced that its research on trends and developments in drug delivery has identified a breakthrough technology that accelerates pharmaceutical product market introductions by generic and drug delivery companies. This development is particularly relevant to producers of drugs offered in the form of orally disintegrating tablets (“ODTs”), a $2.4 billion market. They are now able to offer the same drug in the form of an “orally-dissolving strip,” also known as an Oral Thin Film (“OTF”), with the filing of an Abbreviated New Drug Application (“ANDA”) with the US Food and Drug Administration (“FDA”). This is a major cost of goods saver for generics. The FDA has approved the change in dosage form for drug products as long as there are no questions about the safety or effectiveness of the product. This requires that the uses, dosage and route of administration of the proposed drug product are the same as the listed drug product. This was the basis on which Pepcid AC(R) could also be offered in the form of an OTF. In Technology Catalysts’ recently-released report on “Orally Disintegrating Tablet and Film Technologies” (3rd Edition), the company identified over 15 companies actively developing OTF delivery technologies that enable the shift from a tablet form to a fast-dissolving and highly water-soluble wafer or film.
    [Show full text]
  • Dissolving Diphenhydramine: What Is the Most Efficient Form and Brand of Diphenhydramine?
    CALIFORNIA STATE SCIENCE FAIR 2017 PROJECT SUMMARY Name(s) Project Number Julia M. Abele J2101 Project Title Dissolving Diphenhydramine: What Is the Most Efficient Form and Brand of Diphenhydramine? Abstract Objectives/Goals I conducted this experiment to determine which form (tablet, capsule, or liquigel) and which brand (Benadryl, CVS, or Walgreens) of quick-relief allergy medicine (diphenhydramine) dissolves the fastest in simulated stomach fluid and thus offers the fastest relief. Methods/Materials To make the stomach fluid, I used 150 milliliters of water and 75 milliliters of hydrochloric acid. I placed a diphenhydramine tablet in the fluid, swirled every two minutes, and measured how long the tablet took to dissolve. I conducted this process for Benadryl, CVS, and Walgreens tablets, capsules, and liquigels. I conducted six trials. Results The tablets (at just over 10 minutes on average) dissolved faster than the capsules (nearly 30 minutes) and liquigels (over an hour). The Benadryl tablets dissolved the fastest, but the Benadryl liquigels were the slowest. Conclusions/Discussion The results and data support my hypothesis that the gelatin or silica gel coating on the capsules and liquigels delays dissolution. Also, the Benadryl tablets dissolved faster than their generic equivalents, supporting my hypothesis that Benadryl's unique combination of ingredients, including the superdisintegrant croscarmellose sodium, aids dissolution. The CVS tablets, which have a different superdisintegrant, were not far behind. The next time I have an allergic reaction, I will take a Benadryl or CVS tablet. Summary Statement I learned that Benadryl tablets dissolve faster than other forms and brands of diphenhydramine and thus offer the fastest relief for allergy symptoms.
    [Show full text]
  • Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation
    Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2013 CMC Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Silver Spring, MD 20993 Phone: 301-796-3400; Fax: 301-847-8714 [email protected] http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2013 CMC Contains Nonbinding Recommendations TABLE OF CONTENTS I. INTRODUCTION............................................................................................................. 1 II. BACKGROUND ............................................................................................................... 1 III. DISCUSSION .................................................................................................................... 2 A. Guidelines and Criteria ................................................................................................................. 3 B. Nomenclature and Product Labeling ........................................................................................... 5 Contains Nonbinding Recommendations
    [Show full text]